Morphine Sulfate Extended-Release is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is Morphine Sulfate.
Product ID | 57664-197_916c8c9c-c86a-4e82-9a89-cf0c7fdeb385 |
NDC | 57664-197 |
Product Type | Human Prescription Drug |
Proprietary Name | Morphine Sulfate Extended-Release |
Generic Name | Morphine Sulfate Extended-release |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2016-09-13 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA205634 |
Labeler Name | Sun Pharmaceutical Industries, Inc. |
Substance Name | MORPHINE SULFATE |
Active Ingredient Strength | 200 mg/1 |
Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
DEA Schedule | CII |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2016-09-13 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA205634 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-09-13 |
Ingredient | Strength |
---|---|
MORPHINE SULFATE | 200 mg/1 |
SPL SET ID: | 6208902e-4e2f-4b91-8a24-29f122aa7b24 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
57664-190 | Morphine Sulfate Extended-Release | Morphine Sulfate Extended-Release |
57664-191 | Morphine Sulfate Extended-Release | Morphine Sulfate Extended-Release |
57664-192 | Morphine Sulfate Extended-Release | Morphine Sulfate Extended-Release |
57664-196 | Morphine Sulfate Extended-Release | Morphine Sulfate Extended-Release |
57664-197 | Morphine Sulfate Extended-Release | Morphine Sulfate Extended-Release |